Towards New Delivery Agents for Boron Neutron Capture Therapy: Synthesis and In Vitro Evaluation of a Set of Fluorinated Carbohydrate Derivatives
Molecules · 2024
DOI: 10.3390/molecules29174263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Jelena Matović und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Helsinki, FI-00014 Helsinki, Finland. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Carbohydrates, Halogenation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jane and Aatos Erkko Foundation, Research Council of Finland, Syöpäsäätiö.
Abstract (Originalsprache)
Boron Neutron Capture Therapy (BNCT) is a cancer treatment which combines tumor-selective boron delivery agents with thermal neutrons in order to selectively eradicate cancer cells. In this work, we focus on the early-stage development of carbohydrate delivery agents for BNCT. In more detail, we expand upon our previous GLUT-targeting approach by synthesizing and evaluating the potential embedded in a representative set of fluorinated carbohydrates bearing a boron cluster. Our findings indicate that these species may have advantages over the boron delivery agents in current clinical use, e.g., significantly improved boron delivery capacity at the cellular level. Simultaneously, the carbohydrate delivery agents were found to bind strongly to plasma proteins, which may be a concern requiring further action before progression to in vivo studies. Altogether, this work brings new insights into factors which need to be accounted for if attempting to develop theranostic agents for BNCT based on carbohydrates in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Helsinki, FI-00014 Helsinki, Finland.
- School of Pharmacy, University of Eastern Finland, FI-70211 Kuopio, Finland.
- Glykos Finland Ltd., FI-00790 Helsinki, Finland.
ORCID-Profile: Jelena Matović, Juulia Järvinen, Mirkka Sarparanta, Jarkko Rautio, Filip S Ekholm
Förderung
- Jane and Aatos Erkko Foundation
- Research Council of Finland
- Syöpäsäätiö
- Ruth and Nils-Erik Stenbäck foundation
- University of Helsinki
- Deerfield Management Company L.P.
- Aviko Radiopharmaceuticals Inc.
- Cancer Foundation of Finland
Zitieren
APA
Matović, J., Järvinen, J., Sokka, I. K., Imlimthan, S., Aitio, O., Sarparanta, M., Rautio, J., & Ekholm, F. S. (2024). Towards New Delivery Agents for Boron Neutron Capture Therapy: Synthesis and In Vitro Evaluation of a Set of Fluorinated Carbohydrate Derivatives. Molecules. https://doi.org/10.3390/molecules29174263
Vancouver
Matović J, Järvinen J, Sokka IK, Imlimthan S, Aitio O, Sarparanta M, et al. Towards New Delivery Agents for Boron Neutron Capture Therapy: Synthesis and In Vitro Evaluation of a Set of Fluorinated Carbohydrate Derivatives. Molecules. 2024. doi:10.3390/molecules29174263
BibTeX
@article{Matovi2024,
author = {Matović, Jelena and Järvinen, Juulia and Sokka, Iris K and Imlimthan, Surachet and Aitio, Olli and Sarparanta, Mirkka and Rautio, Jarkko and Ekholm, Filip S},
title = {Towards New Delivery Agents for Boron Neutron Capture Therapy: Synthesis and In Vitro Evaluation of a Set of Fluorinated Carbohydrate Derivatives},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29174263}
}
EUVIMED